레이저 치료 시장 : 기기 유형별, 용도별, 최종사용자별, 지역별, 기회, 예측(2018-2032년)

Global laser therapy market is projected to witness a CAGR of 10.85% during the forecast period 2025-2032, growing from USD 5.24 billion in 2024 to USD 11.95 billion in 2032. The market for laser therapy is anticipated to grow due to its precision and targeted treatment capabilities.

Laser therapy is a medical process that targets specific body parts with focused light to perform precise surgical or cosmetic treatments, promote healing, or lessen pain. Technological developments, such as creating fractional and high-precision diode lasers, are increasing the efficacy and variety of laser therapies, drawing in a wide patient base. Increased interest in cosmetic enhancements and the prevalence of chronic illnesses further drive the demand. The market for laser therapy is anticipated to rise rapidly worldwide as patients and healthcare professionals favor non-invasive or minimally invasive treatments that deliver accuracy, reduce recovery time, and provide efficient outcomes. For instance, in February 2024, Iridex Corporation, a global leader in laser-based medical systems, received European Patent EP 3009093 for MicroPulse devices use; this patented technology delivers precise, short, controlled-width pulse trains, minimizing the risk of full-thickness retinal damage and vision loss. The advanced system employs a diode pump and frequency-doubled solid-state laser to achieve targeted, safe tissue activation without photocoagulation, with proven safety and efficacy in clinical settings.

Increasing Prevalence of Chronic Diseases and Aesthetic Procedures

The increasing prevalence of chronic diseases and aesthetic procedures is one of the major drivers for the laser therapy market. Chronic conditions, such as arthritis, back pain, and neuropathies, increase the demand for non-invasive, pain-relieving options, and laser therapy is emerging as a first choice for pain management and tissue healing. The growing interest in cosmetic treatments to fight against signs of anti-aging and rejuvenate the skin, coupled with increasing popularity in hair removal, is driving this segment toward expanding even further uses of laser cosmetic treatments. Therefore, the enlarging application of laser treatment for medical and aesthetic purposes is driving the market forward worldwide. Stakeholders' attempts to develop novel approaches and products further fuel the market growth.

For instance, in April 2024, Domer Technology, Inc. launched two new laser devices, the Class 3B cold laser and a high-intensity Class 4 laser, for human and animal use. These devices support pain management and injury recovery by increasing blood flow and reducing inflammation. The Class 4 laser, with over 500mW output, provides faster treatment (5-10 minutes) and requires professional training. Laser therapy, noted by specialists for boosting immunity and mobility, is gaining popularity as an alternative or complementary option to traditional pain management methods.

Technological Advancements and Rising Demand for Non-Invasive Treatment Drive the Market

Technological advancements and the rising demand for non-invasive treatments are key growth drivers for the laser therapy market. Continuous innovation in laser technologies with the emergence of high-precision fractional lasers and low-level laser therapy (LLLT) significantly improves treatment efficacy and safety. These enable the tissues to be more accurately targeted, reducing side effects and improving patient outcomes. In addition, consumers' preference for non-invasive procedures is rising due to various factors, such as a relatively shorter recovery time, minimum discomfort, and fewer complications, leading to increased demand for laser therapy. For instance, in February 2024, BIOLASE, Inc. launched the Waterlase iPlus Premier Edition, an advanced all-tissue laser system. This update to the industry-leading Waterlase iPlus showcases the latest innovations in dental care, further solidifying BIOLASE, Inc.'s position as a global leader in dental laser technology.

Dermatology and Aesthetics Segment to Dominate the Laser Therapy Market

The dermatology and aesthetics segment is the most common therapy area in laser therapy treatment for several reasons, primarily driven by increased population-based conditions of skin-related disorders. The development of laser technologies, such as fractional and ablative lasers, makes the treatment more effective, thus increasing the number of applications for treating acne, wrinkles, pigmentation, and hair removal. Rising demand for aesthetic procedures and a desire for minimally invasive solutions that allow for rapid recovery and minimal discomfort will further propel this market segment. For instance, in March 2024, Reveal Lasers LLC launched the AlloraPro Laser Workstation, a cutting-edge device for permanent hair reduction and skin rejuvenation. Featuring 755nm Alexandrite and 1064nm wavelengths, the AlloraPro offers fast, permanent hair removal and targets vascular and pigmented lesions. It treats all skin types efficiently with six ergonomic handpieces and a 30mm spot size. Its intuitive user interface, with color-coded screens, allows providers to customize treatments based on patient skin type, hair density, and thickness.

North America Dominates the Laser Therapy Market

The North American region is anticipated to dominate the laser therapy market for several reasons, including advanced healthcare infrastructure and an increasing number of non-invasive treatments. The region's strong emphasis on technological innovation, along with the increasing requirement for aesthetic procedures and pain management therapies, has helped take the position. Furthermore, the increasing prevalence of chronic diseases, such as arthritis, back pain, and neuropathies, in North American countries like the United States and Canada further increases the demand for non-invasive treatment, fueling the growth of the laser therapy market. Efforts from key market players enhance the growth rate of the market. For instance, in November 2024, Koninklijke Philips N.V. enrolled the first patient in the United States's THOR IDE clinical trial for its new catheter that combines laser atherectomy and intravascular lithotripsy, treatment of peripheral artery disease into a single procedure to enhance patient safety and outcomes.

Future Market Scenario (2025-2032F)

The future market scenario for the global laser therapy market is also strong, with continuous growth resulting from the continuous development of new technologies, further extension of applications in the field of medicine and aesthetic practice, and a drift to minimally invasive methods. The implementation of high-intensity lasers, as well as wavelength-specific devices, will improve the treatment in the fields of pain management, dermatology, oncology, and ophthalmology. The growing awareness of laser therapy and its benefits, increasing healthcare expenditures in emerging markets, regulatory approvals, and strategic collaboration among market leaders are the driving factors for this market. For instance, in July 2024, Aspen Laser Systems, LLC launched the Ascent Laser Series, featuring a unique quad-wave laser with combined wavelengths of 670nm, 810nm, 980nm, and 1064nm and 32 watts of power. As a continuation of Aspen Laser Systems, LLC's innovation in photobiomodulation, the Ascent Laser follows the success of the flagship Apex Laser, offering industry-leading red-light power for therapeutic applications.

Key Players Landscape and Outlook

The laser therapy market is characterized by a dynamic and competitive landscape, with numerous key players actively shaping the sector through strategic business agreements, product approvals, and innovations. The market has witnessed a surge in strategic initiatives, including mergers, acquisitions, and partnerships, to expand portfolios and enhance technological capabilities.

For instance, in June 2024, ClearPoint Neuro, Inc. launched its SmartFrame OR platform and ClearPoint Prism Neuro Laser Therapy System, aiming to make Deep Brain Stimulation more accessible across a broader range of hospitals, potentially expanding treatment options for patients with conditions like Parkinson's disease and Essential Tremor.

For instance, in June 2024, Lumenis Be. Ltd. launched FoLix, the first FDA-cleared fractional laser for hair loss treatment. Designed for both men and women, FoLix utilizes proprietary fractional laser technology to offer a safe, effective, and natural solution for hair loss, requiring no chemicals, needles, or surgery. The system provides results in 4-6 sessions, addressing the widespread issue of hair loss, which affects over 85% of men and 50% of women.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Laser Therapy Market Outlook, 2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Device Type
    • 4.2.1.1. Solid-State Laser
    • 4.2.1.2. Gas Laser
    • 4.2.1.3. Liquid Laser
    • 4.2.1.4. Semiconductor Laser
  • 4.2.2. By Application
    • 4.2.2.1. Dermatology and Aesthetics
    • 4.2.2.2. Ophthalmology
    • 4.2.2.3. Cardiovascular
    • 4.2.2.4. Urology
    • 4.2.2.5. Gynecology
    • 4.2.2.6. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Specialized Clinics
    • 4.2.3.3. Ambulatory Surgical Centers
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia-Pacific
    • 4.2.4.4. South America
    • 4.2.4.5. Middle East and Africa
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 4.3. Market Map Analysis, 2024
  • 4.3.1. By Device Type
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. North America Laser Therapy Market Outlook, 2018-2032F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Device Type
    • 5.2.1.1. Solid-State Laser
    • 5.2.1.2. Gas Laser
    • 5.2.1.3. Liquid Laser
    • 5.2.1.4. Semiconductor Laser
  • 5.2.2. By Application
    • 5.2.2.1. Dermatology and Aesthetics
    • 5.2.2.2. Ophthalmology
    • 5.2.2.3. Cardiovascular
    • 5.2.2.4. Urology
    • 5.2.2.5. Gynecology
    • 5.2.2.6. Others
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals
    • 5.2.3.2. Specialized Clinics
    • 5.2.3.3. Ambulatory Surgical Centers
    • 5.2.3.4. Others
  • 5.2.4. By Country Share
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Laser Therapy Market Outlook, 2018-2032F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Device Type
        • 5.3.1.2.1.1. Solid-State Laser
        • 5.3.1.2.1.2. Gas Laser
        • 5.3.1.2.1.3. Liquid Laser
        • 5.3.1.2.1.4. Semiconductor Laser
      • 5.3.1.2.2. By Application
        • 5.3.1.2.2.1. Dermatology and Aesthetics
        • 5.3.1.2.2.2. Ophthalmology
        • 5.3.1.2.2.3. Cardiovascular
        • 5.3.1.2.2.4. Urology
        • 5.3.1.2.2.5. Gynecology
        • 5.3.1.2.2.6. Others
      • 5.3.1.2.3. By End-user
        • 5.3.1.2.3.1. Hospitals
        • 5.3.1.2.3.2. Specialized Clinics
        • 5.3.1.2.3.3. Ambulatory Surgical Centers
        • 5.3.1.2.3.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Laser Therapy Market Outlook, 2018-2032F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Laser Therapy Market Outlook, 2018-2032F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Laser Therapy Market Outlook, 2018-2032F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Laser Therapy Market Outlook, 2018-2032F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

• 17.1. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

• 20.1. Competition Matrix of Top 5 Market Leaders
• 20.2. SWOT Analysis for Top 5 Players
• 20.3. Key Players Landscape for Top 10 Market Players
  • 20.3.1. Biolitec AG
    • 20.3.1.1. Company Details
    • 20.3.1.2. Key Management Personnel
    • 20.3.1.3. Products and Services
    • 20.3.1.4. Financials (As Reported)
    • 20.3.1.5. Key Market Focus and Geographical Presence
    • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 20.3.2. Boston Scientific Corporation
  • 20.3.3. Lumenis Be Ltd.
  • 20.3.4. Coherent, Inc.
  • 20.3.5. Hologic, Inc.
  • 20.3.6. LaserStar Technologies Corporation
  • 20.3.7. Lumentum Holdings Inc.
  • 20.3.8. Focuslight Technologies Inc.
  • 20.3.9. IPG Photonics Corporation
  • 20.3.10. Lumibird Medical Group

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer